JP2025501978A5 - - Google Patents
Info
- Publication number
- JP2025501978A5 JP2025501978A5 JP2024539848A JP2024539848A JP2025501978A5 JP 2025501978 A5 JP2025501978 A5 JP 2025501978A5 JP 2024539848 A JP2024539848 A JP 2024539848A JP 2024539848 A JP2024539848 A JP 2024539848A JP 2025501978 A5 JP2025501978 A5 JP 2025501978A5
- Authority
- JP
- Japan
- Prior art keywords
- adc
- amino acid
- pharmaceutical product
- subject
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263296831P | 2022-01-05 | 2022-01-05 | |
| US63/296,831 | 2022-01-05 | ||
| US202263304136P | 2022-01-28 | 2022-01-28 | |
| US63/304,136 | 2022-01-28 | ||
| PCT/US2023/060062 WO2023133388A2 (en) | 2022-01-05 | 2023-01-04 | Methods for treating muscle invasive urothelial cancer or muscle invasive bladder cancer with antibody drug conjugates (adc) that bind to 191p4d12 proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501978A JP2025501978A (ja) | 2025-01-24 |
| JP2025501978A5 true JP2025501978A5 (https=) | 2026-01-08 |
Family
ID=87074240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539848A Pending JP2025501978A (ja) | 2022-01-05 | 2023-01-04 | １９１ｐ４ｄ１２タンパク質に結合する抗体薬物コンジュゲート（ａｄｃ）で筋層浸潤性尿路上皮癌または筋層浸潤性膀胱癌を治療するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250064956A1 (https=) |
| EP (1) | EP4460332A2 (https=) |
| JP (1) | JP2025501978A (https=) |
| KR (1) | KR20240137135A (https=) |
| CN (1) | CN119838023A (https=) |
| AU (1) | AU2023205782A1 (https=) |
| CA (1) | CA3242837A1 (https=) |
| IL (1) | IL313915A (https=) |
| MX (1) | MX2024008174A (https=) |
| TW (1) | TW202333801A (https=) |
| WO (1) | WO2023133388A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020020466A2 (pt) * | 2018-04-06 | 2021-01-12 | Seattle Genetics, Inc. | Conjugados de peptídeo de camptotecina |
| AU2019392090A1 (en) | 2018-12-03 | 2021-06-17 | Agensys, Inc. | Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof |
| WO2025021073A1 (zh) * | 2023-07-21 | 2025-01-30 | 江苏迈威康新药研发有限公司 | 抗Nectin4抗体药物偶联物和抗PD-1抗体的药物组合以及其用途 |
| WO2025064741A1 (en) * | 2023-09-21 | 2025-03-27 | Agensys, Inc. | Treating locally advanced or metastatic urothelial cancer with anti-191p4d12 antibody drug conjugates in combination with pembrolizumab |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150292030A1 (en) * | 2012-11-27 | 2015-10-15 | Board Of Regents, The University Of Texas System | Methods of characterizing and treating molecular subset of muscle-invasive bladder cancer |
-
2023
- 2023-01-04 JP JP2024539848A patent/JP2025501978A/ja active Pending
- 2023-01-04 US US18/724,594 patent/US20250064956A1/en active Pending
- 2023-01-04 CA CA3242837A patent/CA3242837A1/en active Pending
- 2023-01-04 WO PCT/US2023/060062 patent/WO2023133388A2/en not_active Ceased
- 2023-01-04 EP EP23737701.5A patent/EP4460332A2/en active Pending
- 2023-01-04 IL IL313915A patent/IL313915A/en unknown
- 2023-01-04 TW TW112100235A patent/TW202333801A/zh unknown
- 2023-01-04 KR KR1020247026352A patent/KR20240137135A/ko active Pending
- 2023-01-04 CN CN202510006527.3A patent/CN119838023A/zh active Pending
- 2023-01-04 AU AU2023205782A patent/AU2023205782A1/en active Pending
-
2024
- 2024-06-27 MX MX2024008174A patent/MX2024008174A/es unknown